In glioma, NR2F2 hypermethylation is a differentially expressed methylated gene between glioma patients with better prognosis and poor prognosis, which is enriched in diseases and disorders in both molecular and cellular aspects (Shinawi et al., 2013). The gene discussed is NR2F2; the disease is central nervous system cancer.